Gotham Asset Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Gotham Asset Management's ORGO Position: Q3 2022 in Review
Gotham Asset Management sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 11,865 shares — an estimated $58K sold.
Gotham Asset Management first reported a position in ORGO in Q3 2021 and held it in 4 quarters. The position peaked at $332K in Q4 2021. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.
- Gotham Asset Management reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
- Gotham Asset Management sold 11,865 Organogenesis Holdings shares in Q3 2022, an estimated $58K.
- Gotham Asset Management first reported a position in Organogenesis Holdings in Q3 2021 and held it in 4 quarters.
- Gotham Asset Management's Organogenesis Holdings position peaked at $332K in Q4 2021.
- 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.
Based on Gotham Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.